CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-06 | Jones William Benton See Remarks | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2023-12-06 | Mitchell Edith P. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-12-06 | Grais Linda Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-12-06 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-12-06 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-12-06 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-12-06 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-15 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-15 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-15 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-15 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-15 | Grais Linda Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-15 | Mitchell Edith P. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-15 | Grais Linda Director | Purchase | +10,000 | $2.45 | $25K | 10,000 |
| 2023-03-31 | MILLER RICHARD A MD President and CEO | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2022-12-20 | Jones William Benton See Remarks | Purchase | +20,000 | $0.79 | $16K | 133,773 |
| 2022-12-14 | LEA LEIV Chief Financial Officer | Purchase | +4,000 | $0.84 | $3K | 133,238 |
| 2022-12-14 | MILLER RICHARD A MD President and CEO | Purchase | +10,000 | $0.78 | $8K | 1,490,119 |
| 2022-12-13 | LEA LEIV Chief Financial Officer | Purchase | +30,000 | $0.74 | $22K | 129,238 |
| 2022-12-13 | MILLER RICHARD A MD President and CEO | Purchase | +50,000 | $0.74 | $37K | 1,480,119 |
Page 5 of 15 · 286 trades